Clinical Trials · NCT01432938
A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 28
- Start date
- Sep 2011
- Locations
- 1 site, United States
- Primary endpoint
- Pharmacokinetics: Area Under the Concentration Versus Time Curve (AUC) of R-warfarin and S-warfarin